Caridad Pontes Garcia

Research activity per year

If you made any changes in Pure these will be visible here soon.

Research interests

PhD in Medicine from the Autonomous University of Barcelona and specialist in Clinical Pharmacology via MIR.
Since 2016 senior management position at the Catalan Health Service, in relation to drug management; currently Manager of Medicines in the Healthcare Area, and representative of Catalonia in the Permanent Pharmacy Commission of the Spanish Interterritorial Health Council and in the Interministerial Commission for Drug Prices.
Associate Professor of the Department of Pharmacology, Therapeutics and Toxicology at the Autonomous University of Barcelona since 2010.
Consultant physician in Clinical Pharmacology at Parc Taulí Hospital (Sabadell) between 2011 and 2016; member of the Pharmacotherapeutic Committee and the Clinical Research Ethics Committee.
Support to EMA scientific advice as a European Expert appointed by the AEMPS between 2010 and 2016.
Previously, 15 years of experience in the pharmaceutical industry, mainly in clinical development in early stages.

Areas of expertise: Drug development, design, methodology and ethical evaluation of clinical trials and observational studies. Regulation of clinical studies. Drug regulation. Evaluation and therapeutic positioning of drugs. Access. price and reimbursement of medicines. Pharmacovigilance and pharmacoepidemiology. Orphan diseases. Medical education. Early-phase clinical trials, first in human trials.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Education/Academic qualification

Ph. D., Universitat Autònoma de Barcelona (UAB)

Award Date: 15 Oct 2004

Postgraduate, Ministerio de Educación y Ciencia

Award Date: 31 Dec 1994

Degree, Universitat Autònoma de Barcelona (UAB)

Award Date: 1 Jun 1990

Baccalaureate, Centro Integrado Público de Formación Profesional Ausiàs March

Award Date: 1 Jun 1984

External positions

Manager for Medicinal Products, Servei Català de la Salut (CatSalut)

3 Jan 2020 → …

Manager of Pharmacotherapeutic Harmonization, Servei Català de la Salut (CatSalut)

15 Jun 2016 → 2 Jan 2020

Consultant- Clinical Pharmacology Unit, Consorci Corporació Sanitària Parc Taulí de Sabadell

16 Jan 2011 → 14 Jun 2016

Cap d'Investigació Clínica i Assumptes Regulatoris. Directora Mèdica., Palau Pharma S.A.

6 Dec 2006 → 15 Jan 2011

Responsable Europea de farmacoepidemiologia i farmacoeconomia. Responsable Espanyola de Farmacovigilància. Vice-responsable Europea de Farmacovigilància, Procter & Gamble Pharmaceuticals. (Egham, Reino Unido)

1 Oct 2005 → 5 Dec 2006

Responsable de farmacovigilància i comunicacions médiques, Vita Científica S.L., a Procter & Gamble Company. (Barcelona)

1 Aug 2004 → 30 Sep 2005

Cap de Departament de Farmacologia Clínica, Laboratorios Vita S.A. (Barcelona)

1 Jan 2002 → 31 Jul 2004

Monitor assaigs clínics. Gestor de projectes. Cap de secció de Farmacologia Clínica, J Uriach & Cía S.A. (Barcelona)

1 Sep 1996 → 31 Dec 2001

Metge Adjunt, Servei de Farmacologia Clínica. Hospital Vall d¿Hebrón. (Barcelona)

1 May 1995 → 31 Aug 1996

Fingerprint

Dive into the research topics where Caridad Pontes Garcia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

2 Finished

Advances in small trials design for regulatory innovation and excellence- ASTERIX
Pontes Garcia, C., Torres, F., Fontanet Sacristan, J. M., Pesiou , S., Ríos Guillermo, J., Sancho López, A., Torrent Farnell, J. & Vives Vilagut, R.
1/10/13 → 30/09/17
Project
Advances in small trials design for regulatory innovation and excellence- ASTERIX
Torres, F., Campillo Grau, M. M., Fontanet Sacristan, J. M., Morros Pedros, R. M., Pardo Carrasco, L., Pontes Garcia, C., Ríos Guillermo, J., Torrent Farnell, J. & Vives Vilagut, R.
1/10/13 → 30/09/17
Project

1319 Citations
17 h-Index
78 Article
3 Review article
1 Chapter

Use of healthcare resources and drug expenditure before and after treatment of chronic hepatitis C with direct antiviral agents
Vergara Gómez, M., Miquel Planas, M., Vela, E., Cleries, M., Pontes, C., Prat Casanovas, M. A. & Rué, M., 11 Mar 2021, In: Journal of Viral Hepatitis. 28, 5, p. 728-738 11 p.
Research output: Contribution to journal › Article › Research › peer-review
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
Godman, B., Hill, A., Simoens, S., Selke, G., Selke Krulichová, I., Zampirolli Dias, C., Martin, A. P., Oortwijn, W., Timoney, A., Gustafsson, L., Voncina, L., Kwon, H-Y., Gulbinovic, J., Gotham, D., Wale, J., Silva, W. C. D., Bochenek, T., Allocati, E., Kurdi, A., Ogunleye, O. O. & 30 others, Meyer, J. C., Hoxha, I., Malaj, A., Hierländer, C., Sauermann, R., Hamelinck, W., Petrova, G., Laius, O., Langner, I., Yfantopoulos, J., Joppi, R., Jakupi, A., Greiciute-Kuprijanov, I., Vella Bonanno, P., Piepenbrink, J. H., de Valk, V., Wladysiuk, M., Marković-Peković, V., Mardare, I., Fürst, J., Tomek, D., Obach Cortadellas, M., Zara, C., Pontes, C., McTaggart, S., Laba, T-L., Melien, Ø., Wong-Rieger, D., Bae, S. & Hill, R., 4 Feb 2021, (E-pub ahead of print) In: Expert Review of Pharmacoeconomics and Outcomes Research.
Research output: Contribution to journal › Article › Research › peer-review
12 Citations (Scopus)
Time Trends of Crohn’s Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery
Pontes Garcia, C., 8 Sep 2020, In: Journal of Clinical Medicine. 9, 9, p. 2896
Research output: Contribution to journal › Article › Research › peer-review

3 Citations (Scopus)
Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics
Bakkum, M. J., Tichelaar, J., Papaioannidou, P., Likic, R., Sanz Alvarez, E. J., Christiaens, T., Costa, J. N., Mačiulaitis, R., Dima, L., Coleman, J., Richir, M. C., van Agtmael, M. A., Atanasova, I., Ganeva, M., Gatchev, E., Kostadinova, I. I., Mimica Matanovic, S., Vitezic, D., Greta, W., Kmonickova, E. & 74 others, Karel, U., Damkier, P., Huupponen, R. K., Auffret, M., Bejan-Angoulvant, T., Laurent, C., Jean-Luc, C., Drici, M. D., Faillie, J. L., Hélène, G., Molimard, M., Orlikowski, D., Palin, K., Pers, Y. M., Picard, N., Simon, N., Toussirot, E., Boger, R. H., Cascorbi, I., Mueller, S. C., Regenthal, R., Schwab, M., Schwaninger, M. S., Thuermann, P. A., Wojnowski, L., Kouvelas, D., Riba, P., Kerins, D. M., Williams, D. J., Cosentino, M., De Ponti, F., Filippelli, A., Leone, R., Locatelli, V., Jansone, B., Gulbinovic, R., Mifsud, J., Braszko Jan, J., Kocic, I., Luiza, B., Castelo-Branco, M., Simona, C., Ioan, M., Bevc, S., Mojca, K., Bernal, M. L., Capellà, D., Carcas, A., De Abajo, F. J., Lopez-Rico, M., Lucena, M. I., Pontes, C., Sanz, E. J., Böttiger, Y., Le Grevès, M., de Waard-Siebinga, I., Janssen Ben, J. A., Wilma, K., Rahul, P., van Rosse, F., Dent, G., Albert, F., Hitchings, A. W., Kapil, V., Linton, K. D., Loke, Y. K., Michael, O., David, P. R., Pontefract, S., Ranmuthu, S., Sampson, A. P., Thanacoody, H. K. R., Whitfield Jonathan, P. & Wilson, K., 1 Aug 2020, In: British Journal of Clinical Pharmacology. 11 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
2 Citations (Scopus)
Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: A systematic analysis of the literature and meta-analysis
Vinson, D., Molet-Benhamou, L., Degboé, Y., Den Broeder, A., Ibrahim, F., Pontes, C., Westhovens, R., Závada, J., Pham, T., Barnetche, T., Constantin, A. & Ruyssen-Witrand, A., 29 Apr 2020, In: Arthritis Research and Therapy. 22, 1, p. 97 11 p., 97.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
5 Citations (Scopus)

Caridad Pontes Garcia

Personal profile

Research interests

Expertise related to UN Sustainable Development Goals

Education/Academic qualification

External positions

Fingerprint

Network

Dive into details

Advances in small trials design for regulatory innovation and excellence- ASTERIX

Advances in small trials design for regulatory innovation and excellence- ASTERIX

Use of healthcare resources and drug expenditure before and after treatment of chronic hepatitis C with direct antiviral agents

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Time Trends of Crohn’s Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery

Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics

Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: A systematic analysis of the literature and meta-analysis

Caridad Pontes Garcia

Personal profile

Research interests

Expertise related to UN Sustainable Development Goals

Education/Academic qualification

External positions

Fingerprint

Network

Projects

Advances in small trials design for regulatory innovation and excellence- ASTERIX

Advances in small trials design for regulatory innovation and excellence- ASTERIX

Research output

Use of healthcare resources and drug expenditure before and after treatment of chronic hepatitis C with direct antiviral agents

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Time Trends of Crohn’s Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery

Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics

Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: A systematic analysis of the literature and meta-analysis